TearLab (TEAR - Get Report) is an in-vitro diagnostic company. TearLab is commercializing a tear testing platform, the TearLab Osmolarity System that enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. This stock is trading up 5% to $3.35 in recent trading.
Today's Range: $3.17-$3.7052-Week Range: $0.78-$4.88 Volume: 164,000 Three-Month Average Volume: 163,117 >>5 Health Care Stocks Setting Up to Break Out From a technical perspective, TEAR is ripping higher here back above its 50-day moving average of $3.32 with decent volume. This move has also pushed the stock into breakout territory, since TEAR has flirted with some near-term overhead resistance at $3.31 to $3.40. At last check, TEAR has hit an intraday high of $3.70 and volume is just starting to move above its three-month average action of 163,117 shares. Traders should now look for long-biased trades as long as TEAR is trending above its 50-day at $3.32, and once it takes out today's high of $3.70 with strong volume. I would consider any upside volume day that registers near or above 163,117 shares as bullish. If we get that action soon, then TEAR has a great chance of re-test and possibly taking out its next significant overheard resistance levels at $4.35 to $4.88 a share.